PD-L1 Distribution and Perspective for Cancer Immunotherapy—Blockade, Knockdown, or Inhibition

Cancer immunotherapy involves blocking the interactions between the PD-1/PD-L1 immune checkpoints with antibodies. This has shown unprecedented positive outcomes in clinics. Particularly, the PD-L1 antibody therapy has shown the efficiency in blocking membrane PD-L1 and efficacy in treating some adv...

Celý popis

Podrobná bibliografie

Vydáno v:	Frontiers in immunology Ročník 10; s. 2022
Hlavní autoři:	Wu, Yilun, Chen, Weiyu, Xu, Zhi Ping, Gu, Wenyi
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Switzerland Frontiers Media S.A 27.08.2019
Témata:	cancer immunotherapy cellular PD-L1 distribution gene silencing Immunology PD-1/PD-L1 immune checkpoint PD-L1 regulation signaling pathway inhibitor cancer immunotherapy gene silencing signaling pathway inhibitor PD-L1 regulation combination therapy PD-1/PD-L1 immune checkpoint cellular PD-L1 distribution
ISSN:	1664-3224, 1664-3224
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!